Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib with Concurrent Radiation for Newly Diagnosed Resectable Rectal Cancer.

Published in:

Oncologist, 2018, v. 23, n. 1, p. 2, doi. 10.1634/theoncologist.2017-0474

By:

• Araujo‐Mino, Emilio P.;
• Patt, Yehuda Z.;
• Murray‐Krezan, Cristina;
• Hanson, Joshua A.;
• Bansal, Pranshu;
• Liem, Ben J.;
• Rajput, Ashwani;
• Fekrazad, M. Houman;
• Heywood, Glenory;
• Lee, Fa Chyi

Publication type:

Article